Vanda Pharmaceuticals Inc (VNDA)
4.97
-0.27
(-5.15%)
USD |
NASDAQ |
Apr 18, 16:00
4.93
-0.04
(-0.80%)
After-Hours: 20:00
Vanda Pharmaceuticals Market Cap: 285.96M for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 285.96M |
| April 17, 2024 | 301.50M |
| April 16, 2024 | 233.03M |
| April 15, 2024 | 233.60M |
| April 12, 2024 | 237.05M |
| April 11, 2024 | 246.26M |
| April 10, 2024 | 246.26M |
| April 09, 2024 | 250.86M |
| April 08, 2024 | 259.49M |
| April 05, 2024 | 277.33M |
| April 04, 2024 | 283.08M |
| April 03, 2024 | 290.56M |
| April 02, 2024 | 224.97M |
| April 01, 2024 | 237.05M |
| March 28, 2024 | 236.48M |
| March 27, 2024 | 223.82M |
| March 26, 2024 | 222.09M |
| March 25, 2024 | 222.67M |
| March 22, 2024 | 223.82M |
| March 21, 2024 | 224.97M |
| March 20, 2024 | 218.64M |
| March 19, 2024 | 216.34M |
| March 18, 2024 | 215.77M |
| March 15, 2024 | 219.22M |
| March 14, 2024 | 218.64M |
| Date | Value |
|---|---|
| March 13, 2024 | 220.94M |
| March 12, 2024 | 223.25M |
| March 11, 2024 | 230.44M |
| March 08, 2024 | 222.67M |
| March 07, 2024 | 219.79M |
| March 06, 2024 | 224.97M |
| March 05, 2024 | 238.21M |
| March 04, 2024 | 245.69M |
| March 01, 2024 | 265.25M |
| February 29, 2024 | 257.19M |
| February 28, 2024 | 257.19M |
| February 27, 2024 | 264.10M |
| February 26, 2024 | 262.37M |
| February 23, 2024 | 256.04M |
| February 22, 2024 | 249.14M |
| February 21, 2024 | 249.71M |
| February 20, 2024 | 250.29M |
| February 16, 2024 | 252.01M |
| February 15, 2024 | 251.44M |
| February 14, 2024 | 244.53M |
| February 13, 2024 | 233.60M |
| February 12, 2024 | 249.14M |
| February 09, 2024 | 239.36M |
| February 08, 2024 | 234.18M |
| February 07, 2024 | 209.44M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
194.46M
Minimum
Nov 09 2023
1.197B
Maximum
Jun 30 2021
631.69M
Average
625.09M
Median
Market Cap Benchmarks
| ADMA Biologics Inc | 1.415B |
| Johnson & Johnson | 351.20B |
| Nektar Therapeutics | 242.38M |
| Invivyd Inc | 280.17M |
| Amicus Therapeutics Inc | 3.054B |
Market Cap Related Metrics
| PE Ratio | 94.98 |
| PS Ratio | 1.486 |
| Price to Book Value | 0.5253 |
| Price to Free Cash Flow | 23.06 |
| Price | 4.97 |
| Earnings Yield | 1.05% |
| Normalized PE Ratio | 94.98 |